Dianthus Therapeutics
4 open jobs
Executive Director, Head of Bioanalytical Sciences
About Us We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s
Applyto Executive Director, Head of Bioanalytical Sciences at Dianthus Therapeutics seen live 1 day ago posted 3 days agoAssociate Director/Director, Clinical Pharmacology and Pharmacometrics
About Us We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s
Applyto Associate Director/Director, Clinical Pharmacology and Pharmacometrics at Dianthus Therapeutics seen live 1 day ago posted 47 days agoAssociate Director, Clinical Operations
About Us We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s
Applyto Associate Director, Clinical Operations at Dianthus Therapeutics seen live 1 day ago posted 47 days agoAssociate Director/Director Drug Product, CMC
About Us We are developing potentially best in class therapies for patients living with severe autoimmune diseases. Our lead antibody, claseprubart (DNTH103), is purposefully engineered with extended half-life, improved potency, and high selectivity for only the active C1s
Applyto Associate Director/Director Drug Product, CMC at Dianthus Therapeutics seen live 1 day ago posted 91 days ago